{"ticker": {"uuid": "3b0ba243-06c2-4d2e-abee-039efa3f695f", "symbol": "LALPATHLAB", "name": "Dr. Lal PathLabs Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Dr. Lal PathLabs' Volume Boom Comes at a Cost", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQUlRCcHUwbGF2OElfUFRRR0MxZl9DLWdJa2Fsa0FGRHd5YjQ5MWx2WThGUmYzMzNmU1NQRDRxSU45enBaeHhaV1JKWXluNzZ0ZFpseEVuRlZ2NVM1bWRTeFZBQmZJRjF5V1hxNURFOHNJUnkyREtBUV9zR1A2emR3dXdZQWdEWmdLazNnZWd3Nlk0cU1JX2tvNWVWelI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-17T09:49:58+00:00", "published_display": "17 Jun 2026 09:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs rises 6% in four sessions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-16T09:02:08+00:00", "published_display": "16 Jun 2026 09:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs soars 11%, hits 52-week high on huge volumes; here's why", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-16T06:54:40+00:00", "published_display": "16 Jun 2026 06:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs surges 9% as it forays into Dubai market with new subsidiary", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-06-16T05:13:27+00:00", "published_display": "16 Jun 2026 05:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQOGozRFdYempIMlZNQV85WGwwUV8yeU9acWdtWHBKUW5acl8tM3o3YjZmeXRPNk5NQzFQc19SME1qT3BzMjlLQzF6NmhPWVU5SXUzUmRSM1lYaFpLNU1CTUhlV0YxNGhuSVBWQUxFbk5pQ2ZjUVp0TnkxNWo2QU1hcXUzS0c5TGxqdmF2LW02SkpFQWsydW5vcUVTZWpjTzIwWDBGM0RVYUFzcm8tMXllSjNDdmM1T3FiSTlrQTBMenh3TnRPOFN6eHRYemE0SFdBTUpJc3Y4M1pxVjQ1NUtr?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Dr Lal Pathlabs; target of Rs 1740: Emkay Global Financial", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Momentum Stocks: Dr Lal PathLabs, JHS Svendgaard, Dar Credit rally on sheer momentum", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs jumps after Q4 results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results \u2014 Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQVmx3MHFVbnI0REtfdDctS0R3RGFFSmdfOG1BcjE0cVJQU2V4YW01VmpsVWZVVUI3TGVTeUpwbU9iN0dLQVhVa0R0ME9aazRvejZReml2aFlJS2gyQ3RGOFE1OVplWU5wUTB6VjdqZTczUWJVcFdzbWJwTGlFOXQ5R0hTVFhPcWhfLVNJTi1zUDdEdVVxRzNQXzJnanM5cHNsdjVhNnI5VDNZZjAxRzJoS1lCTG1IbFJ0SmVaZVhFZDh0Y1pyUHRIQm1CYklIeVU2SmxQbGxrbXZ4WlRfV2M0dXpzb3F2WmNXTHFWQjVWMA?oc=5", "source_name": "NDTV Profit", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For Dr. Lal PathLabs Limited (NSE:LALPATHLAB) After Its Yearly Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOdlh5cDU2SkZwSkxXMlBZZXBxVGwxRkI2OVptNjg5bElHNTdoVm9kd19oWnZqRWxvYVdOMGRrVnlaaVFHd1RYS1hpRVZKa2cxNkMtenNRbThBR05JaFZCX3F1SHRrNHJlMWRpT2R2RjUzNkJYcnlSU3liWlJKbkZidGhYVUU3YkJqdnRxVGMxT0ZialdLX0FaelMyZFQ3YkRmX3c5NTVTOWM1NmRDdk1ZOXNoOHpUQVdDZTRlYURDSHVlSEllVmlUa0picTRLN1RNbjlNMDJ4LUhYdmpRaGJZ0gHkAUFVX3lxTE9YeTZ2V1p0d2VrN0ZYTTVzWTdUYVc5WlV4Y0ZSZmFjTDFJaGpFZVhBSHRTajk0TVNDZEpsbVNZWWNreXMwMXJnNzVSQzFSNnJBdnU4a1pmcExhTV9IUVJoTHBfSXJ0Q09pZVlGR0JlT3B2TmdOZS1mTXdpd2xMTnliNlAxX1NFcnRodGtOTW9XeDh3Q29aZGpsTkVMamhTQUQxTTZZQ2pTQlJuNXIwYXBkZEx0MEJTdjNvSFZnRWZuYmpVay1IeDExcmx3bS1ILXNMZEtpdDJFM19WcGlWa2E0b1piYQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs Completes Full Purchase Of Shahbazkers Diagnostic Centre", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPTnFHRHZUNUQ2R1dOQk5TVTZoNUlPUXN6S085VHh2RGd2TlQzOWI5UGNubEFlazlRTTZMbU4talVfNDRhUnZyemtQYWpWbjVlM0VWbEEzaXUyRjBCTWdvYk5TbC1SSTItaXBvWDh1QWhUbDNhMkNZZ2djbHJwRnFpY3FEX1RxUzN2RlhQc0xxSzltTXZjdHN1M2tTSmZaaGVpMmU2NUtrZzAtdEdxQml5M3ZEQmc3VEFvT2lDelRhRVlPZXZVbFVDVC1rTQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs Q4FY26 Results: Revenue Grows, Profit Declines, Dividend Approved", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZVFBOGxPQmlJalM4LVg5Z0NQQjNfMzYxdTl3S1B3Mm1YSEZ4Ui1xWWNydDlvWlFZejhrdWNKLVNYaXg2ZEQtRUhMUTdJaWVuaHB5X3VNaEQ0Z05GbXJaX1NuM196VGNxbExtQ205a1M3WHlMczVoeVFVaXVuN1N3bDktdVl2WVRFemVuZGVLNWdlX1FYVzFrT0JJdkZEWHFCTXZqQVJ1YWRzMmJydWZnNkZiOTFxYXZSWHF2U2oyOWJ3cnhnbm96Z29BeENPQQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal Pathlabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbEVLQTB5bUp0NFgxUl9xUUJ1YWZ6S2p4YnVQaXFhNWJZWUtWZzRPYVlIQ0x5eFA4cWFZRE9pZzZDVTNMNWZIeWFSMXNkUDBHXzZybjRKYjhWcmVRcTFqR01QT0FpTWNPMEZTS1B0SDJVMFR4VXVjMjRGYnlZUjYyQmpnRTNEXzkzdVY3Y3JHOHh3UWgzdHhRS2NQM2RfcTBIc3JjckdNZW5RQXZrREg2Y2xRaHZvVHk0YkZzZTFzQWtmeFBOOUZkeHJjUDY3ZjJ6YmQ0WE5yc0syelBKeWc?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs readies a war chest for southern push as CFO Goel flags potential big\u2011ticket M&A,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After the recent decline, Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Top Key Executive Arvind Lal's holdings have lost 3.1% of their value", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal Pathlabs Ltd. Share Price Live Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNZ011M3ROdTJ3UkhQbnQyNDUyNVloazBnRFhiYUsxUDRUdHhQTjhpalV5Zlg0VWx4VkVnaGpjakc4Rkp2MW9WUWpmZDU0N1c4MEtXYnQ0Uk1nUnNfanpzT05ROUtfZXBPLTVhaXZBdldTVkVqS3lyQnYwNWlCRlNFWVZMUQ?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T14:51:52+00:00", "published_display": "03 Jan 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-02T08:00:00+00:00", "published_display": "02 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs shares tank 51% today, but here\u2019s why investors shouldn\u2019t panic", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-12-19T08:00:00+00:00", "published_display": "19 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bonus Shares Incoming! Dr. Lal PathLabs Makes It Official; Key Dates Inside For 1:1 Bonus Issue Purpose", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPMTFPNHkxdnJwbXk3clc2OVJyMkRIUmVSX0xkUWZHUlNqclhfWlUwQ0xvQVJOUVl5eGZvbWRrNnR4NW5OZmp0Ty1kX0ZzZHM0VTF4V2VEdWRORk13aTVycGZIYjdfb0RtelBjQmsyaEEyMDZHVU8yT0kwb0E1YzBCMW5CUDFVcmtXX3ZYM3JqblRxNjFDX1M2cXEtVTl6dFVfeXpqRUVFdTBDNHVJNlRUY3Jya3g1dUtfSEI3Ym43OEs4cDI3cWVNU1V3b1F1YjR6WVNKTjBxc1VUZw?oc=5", "source_name": "Goodreturns", "published_at": "2025-12-14T08:00:00+00:00", "published_display": "14 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs (NSE:LALPATHLAB) Could Become A Multi-Bagger", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs Q2: Company declares 2nd interim dividend, bonus share in 1:1 ratio; check all details", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQeVBEZ2NJeVNPT2k4aV9FRnhobkpaMDhrSVpEWERKekNFbDF6c1JBSXQ0cE91SVJlaTdVVXo0M2RXWWhoTUhGRWNFNUt5WlJSYW5oby1qSlFwQzdnQ1FEdlJweHFsT0tRSlduQU5KVkxUYlF2M0tVZTRtM2sxajNoWTZ6N1hqaW1nYUZZWEFNVDJOY2VtTEJkVmVZRkpOVWxWc2NYeEZVYzY1bWNEdnNOVmV6amhWeGZWNjJBNFozdC05bjEwYUQ0UDdfYWo3YXhTN2dFdjY0dFFtTWQycU4wRENsSjJiUDVHRmdxdlk3bE9GaEhOUE1TcA?oc=5", "source_name": "Upstox", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LALPATHLAB.NS - Dr. Lal PathLabs Limited Company Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9Sa2FHQ19kMExvSmdNR2lRZFBtcHZ1Wkcta2JmSm5fSGQxYV8zMVNRX3NLdzF0dV95OERHR1hqNThHSTZzbFlTaE03YThlekJPQ3pR?oc=5", "source_name": "StockInvest.us", "published_at": "2020-08-26T19:07:44+00:00", "published_display": "26 Aug 2020 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Dr. Lal PathLabs' Volume Boom Comes at a Cost", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQUlRCcHUwbGF2OElfUFRRR0MxZl9DLWdJa2Fsa0FGRHd5YjQ5MWx2WThGUmYzMzNmU1NQRDRxSU45enBaeHhaV1JKWXluNzZ0ZFpseEVuRlZ2NVM1bWRTeFZBQmZJRjF5V1hxNURFOHNJUnkyREtBUV9zR1A2emR3dXdZQWdEWmdLazNnZWd3Nlk0cU1JX2tvNWVWelI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-17T09:49:58+00:00", "published_display": "17 Jun 2026 09:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs rises 6% in four sessions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-16T09:02:08+00:00", "published_display": "16 Jun 2026 09:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs soars 11%, hits 52-week high on huge volumes; here's why", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-16T06:54:40+00:00", "published_display": "16 Jun 2026 06:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs surges 9% as it forays into Dubai market with new subsidiary", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-06-16T05:13:27+00:00", "published_display": "16 Jun 2026 05:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQOGozRFdYempIMlZNQV85WGwwUV8yeU9acWdtWHBKUW5acl8tM3o3YjZmeXRPNk5NQzFQc19SME1qT3BzMjlLQzF6NmhPWVU5SXUzUmRSM1lYaFpLNU1CTUhlV0YxNGhuSVBWQUxFbk5pQ2ZjUVp0TnkxNWo2QU1hcXUzS0c5TGxqdmF2LW02SkpFQWsydW5vcUVTZWpjTzIwWDBGM0RVYUFzcm8tMXllSjNDdmM1T3FiSTlrQTBMenh3TnRPOFN6eHRYemE0SFdBTUpJc3Y4M1pxVjQ1NUtr?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Dr Lal Pathlabs; target of Rs 1740: Emkay Global Financial", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Momentum Stocks: Dr Lal PathLabs, JHS Svendgaard, Dar Credit rally on sheer momentum", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs jumps after Q4 results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results \u2014 Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQVmx3MHFVbnI0REtfdDctS0R3RGFFSmdfOG1BcjE0cVJQU2V4YW01VmpsVWZVVUI3TGVTeUpwbU9iN0dLQVhVa0R0ME9aazRvejZReml2aFlJS2gyQ3RGOFE1OVplWU5wUTB6VjdqZTczUWJVcFdzbWJwTGlFOXQ5R0hTVFhPcWhfLVNJTi1zUDdEdVVxRzNQXzJnanM5cHNsdjVhNnI5VDNZZjAxRzJoS1lCTG1IbFJ0SmVaZVhFZDh0Y1pyUHRIQm1CYklIeVU2SmxQbGxrbXZ4WlRfV2M0dXpzb3F2WmNXTHFWQjVWMA?oc=5", "source_name": "NDTV Profit", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For Dr. Lal PathLabs Limited (NSE:LALPATHLAB) After Its Yearly Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs Completes Full Purchase Of Shahbazkers Diagnostic Centre", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPTnFHRHZUNUQ2R1dOQk5TVTZoNUlPUXN6S085VHh2RGd2TlQzOWI5UGNubEFlazlRTTZMbU4talVfNDRhUnZyemtQYWpWbjVlM0VWbEEzaXUyRjBCTWdvYk5TbC1SSTItaXBvWDh1QWhUbDNhMkNZZ2djbHJwRnFpY3FEX1RxUzN2RlhQc0xxSzltTXZjdHN1M2tTSmZaaGVpMmU2NUtrZzAtdEdxQml5M3ZEQmc3VEFvT2lDelRhRVlPZXZVbFVDVC1rTQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs Q4FY26 Results: Revenue Grows, Profit Declines, Dividend Approved", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZVFBOGxPQmlJalM4LVg5Z0NQQjNfMzYxdTl3S1B3Mm1YSEZ4Ui1xWWNydDlvWlFZejhrdWNKLVNYaXg2ZEQtRUhMUTdJaWVuaHB5X3VNaEQ0Z05GbXJaX1NuM196VGNxbExtQ205a1M3WHlMczVoeVFVaXVuN1N3bDktdVl2WVRFemVuZGVLNWdlX1FYVzFrT0JJdkZEWHFCTXZqQVJ1YWRzMmJydWZnNkZiOTFxYXZSWHF2U2oyOWJ3cnhnbm96Z29BeENPQQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal Pathlabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbEVLQTB5bUp0NFgxUl9xUUJ1YWZ6S2p4YnVQaXFhNWJZWUtWZzRPYVlIQ0x5eFA4cWFZRE9pZzZDVTNMNWZIeWFSMXNkUDBHXzZybjRKYjhWcmVRcTFqR01QT0FpTWNPMEZTS1B0SDJVMFR4VXVjMjRGYnlZUjYyQmpnRTNEXzkzdVY3Y3JHOHh3UWgzdHhRS2NQM2RfcTBIc3JjckdNZW5RQXZrREg2Y2xRaHZvVHk0YkZzZTFzQWtmeFBOOUZkeHJjUDY3ZjJ6YmQ0WE5yc0syelBKeWc?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs readies a war chest for southern push as CFO Goel flags potential big\u2011ticket M&A,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After the recent decline, Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Top Key Executive Arvind Lal's holdings have lost 3.1% of their value", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal Pathlabs Ltd. Share Price Live Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNZ011M3ROdTJ3UkhQbnQyNDUyNVloazBnRFhiYUsxUDRUdHhQTjhpalV5Zlg0VWx4VkVnaGpjakc4Rkp2MW9WUWpmZDU0N1c4MEtXYnQ0Uk1nUnNfanpzT05ROUtfZXBPLTVhaXZBdldTVkVqS3lyQnYwNWlCRlNFWVZMUQ?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T14:51:52+00:00", "published_display": "03 Jan 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-02T08:00:00+00:00", "published_display": "02 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs shares tank 51% today, but here\u2019s why investors shouldn\u2019t panic", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-12-19T08:00:00+00:00", "published_display": "19 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bonus Shares Incoming! Dr. Lal PathLabs Makes It Official; Key Dates Inside For 1:1 Bonus Issue Purpose", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPMTFPNHkxdnJwbXk3clc2OVJyMkRIUmVSX0xkUWZHUlNqclhfWlUwQ0xvQVJOUVl5eGZvbWRrNnR4NW5OZmp0Ty1kX0ZzZHM0VTF4V2VEdWRORk13aTVycGZIYjdfb0RtelBjQmsyaEEyMDZHVU8yT0kwb0E1YzBCMW5CUDFVcmtXX3ZYM3JqblRxNjFDX1M2cXEtVTl6dFVfeXpqRUVFdTBDNHVJNlRUY3Jya3g1dUtfSEI3Ym43OEs4cDI3cWVNU1V3b1F1YjR6WVNKTjBxc1VUZw?oc=5", "source_name": "Goodreturns", "published_at": "2025-12-14T08:00:00+00:00", "published_display": "14 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs (NSE:LALPATHLAB) Could Become A Multi-Bagger", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Lal PathLabs Q2: Company declares 2nd interim dividend, bonus share in 1:1 ratio; check all details", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQeVBEZ2NJeVNPT2k4aV9FRnhobkpaMDhrSVpEWERKekNFbDF6c1JBSXQ0cE91SVJlaTdVVXo0M2RXWWhoTUhGRWNFNUt5WlJSYW5oby1qSlFwQzdnQ1FEdlJweHFsT0tRSlduQU5KVkxUYlF2M0tVZTRtM2sxajNoWTZ6N1hqaW1nYUZZWEFNVDJOY2VtTEJkVmVZRkpOVWxWc2NYeEZVYzY1bWNEdnNOVmV6amhWeGZWNjJBNFozdC05bjEwYUQ0UDdfYWo3YXhTN2dFdjY0dFFtTWQycU4wRENsSjJiUDVHRmdxdlk3bE9GaEhOUE1TcA?oc=5", "source_name": "Upstox", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LALPATHLAB.NS - Dr. Lal PathLabs Limited Company Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9Sa2FHQ19kMExvSmdNR2lRZFBtcHZ1Wkcta2JmSm5fSGQxYV8zMVNRX3NLdzF0dV95OERHR1hqNThHSTZzbFlTaE03YThlekJPQ3pR?oc=5", "source_name": "StockInvest.us", "published_at": "2020-08-26T19:07:44+00:00", "published_display": "26 Aug 2020 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 73, "total_relevant": 24, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 18, "score": 52, "total": 24, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 10.7, "count": 15}, {"event": "earnings", "label": "Earnings", "weight": 2.9, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.45, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1635.8, "latest_week": "2026-06-19", "one_week_move": 2.1, "four_week_move": 0.3, "twelve_week_move": 23.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.198972, "market_dynamics_buy_signal": false, "relative_strength": 12.875287, "fair_value_gap": 18.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.7569, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.1% over one week, +0.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 6}, {"label": "Moneycontrol.com", "count": 4}, {"label": "Business Standard", "count": 3}, {"label": "marketscreener.com", "count": 2}, {"label": "The Economic Times", "count": 2}, {"label": "scanx.trade", "count": 2}, {"label": "NDTV Profit", "count": 1}, {"label": "CNBC TV18", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 24}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Earnings", "count": 4}, {"label": "Balance sheet", "count": 2}, {"label": "Capital return", "count": 2}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "24", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "11", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.1% over one week, +0.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Dr. Lal PathLabs' Volume Boom Comes at a Cost"}], "updated_at": "2026-06-22T17:44:58.239159+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}